Ursodeoxycholic acid administration did not reduce susceptibility to SARS‐CoV ‐2 infection in children
Liver International · 2023
DOI: 10.1111/liv.15660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Teng Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: COVID-19, Liver Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and Aims A recent study suggested that administration of ursodeoxycholic acid (UDCA) at dosages usually employed clinically may reduce rates of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. A recent surge of SARS‐CoV‐2 omicron infection in China allowed study of whether UDCA administration reduced susceptibility to SARS‐CoV‐2 infection in children with liver disease.
Methods
Through WeChat groups, a questionnaire was distributed to families ( n = 300) in which a child had been admitted to our liver service in the past 5 years. Among the families/households in which someone was infected with SARS‐CoV‐2, the proportion in which a child taking UDCA was infected was compared with the proportion in which a child not taking UDCA was infected.
Results
Of the 300 questionnaire answers, 280 (93.3%) were valid. SARS‐CoV‐2 infection was confirmed in 226 families (80.7%): 146 children were taking UDCA (10‐20 mg/kg/day) and 80 children were not taking UDCA. SARS‐CoV‐2 infection was confirmed in 95 children taking UDCA (65.1%) and in 51 children not taking UDCA (63.8%) ( p = 0.843); SARS‐CoV‐2 infection was suspected in 23 children taking UDCA (15.8%) and in 11 children not taking UDCA (13.8%) ( p = 0.687).
Conclusions
These results indicate that UDCA administration does not reduce susceptibility to SARS‐CoV‐2 infection in children with liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai, China.
- Department of Pediatrics, Shanghai Medical College, Fudan University, Shanghai, China.
ORCID-Profile: Teng Liu, Jian-She Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, T., & Wang, J. S. (2023). Ursodeoxycholic acid administration did not reduce susceptibility to SARS‐CoV ‐2 infection in children. Liver International. https://doi.org/10.1111/liv.15660
Vancouver
Liu T, Wang JS. Ursodeoxycholic acid administration did not reduce susceptibility to SARS‐CoV ‐2 infection in children. Liver International. 2023. doi:10.1111/liv.15660
BibTeX
@article{Liu2023,
author = {Liu, Teng and Wang, Jian-She},
title = {Ursodeoxycholic acid administration did not reduce susceptibility to SARS‐CoV ‐2 infection in children},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15660}
}
EUVIMED